Pigmentary Retinopathy Clinical Trial
— REVEOfficial title:
Impact de la Restriction du Champ Visuel Sur l'Exploration Visuelle
To communicate with the observer and guide his gaze on the canvas, painters have developed
different stylistic processes that artists, in the manner of scientists, have acquired on the
functioning of human visual perception. This direct communication between the artist and the
observer is strongly impacted for people with visual impairments.
In order to improve the accessibility and autonomy of visually impaired people in museums and
to allow each observer to feel the visual and emotional experience closest to the original
work of the artist, it is essential to identify the modifications. perceptive generated by
the constriction of vision
Status | Recruiting |
Enrollment | 45 |
Est. completion date | October 17, 2021 |
Est. primary completion date | September 11, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Groupe 1 Inclusion Criteria: - no visual pathology - Age = 18 and <65 years - Binocular visual acuity =8 / 10th or = +0.10 logMAR - Comprehension of the written and spoken French language - Signed consent to participate in the study - Health insurance affiliation - Visit to an ophthalmologist less than a year old Exclusion Criteria: - Pregnant or lactating woman - Ocular pathology that may interfere with planned assessments - Treatment that may interfere with planned assessments - Participation in another study that may interfere with this study. - Severe pathology unbalanced or interfering with planned assessments. - Neurological deficit including history of epileptic pathology, photosensitive epilepsy, sensory-motor coordination disorders, vestibular or cerebellar pathology - Inability to give consent personally. - Adults protected by law. Groupe 2 Inclusion Criteria: - Retinopathy pigmentary dystrophy rods-cones. - Binocular visual acuity =4 / 10 (=0.4 logMAR). - Horizontal diameter of the residual Goldmann field of view = 25 ° of binocular diameter at III4. - Comprehension of the French language, written or oral. - Signed consent - Visual assessment less than 6 months old Exclusion Criteria: - Pregnant or nursing woman. - Ocular pathology that may interfere with planned assessments. - Treatment that may interfere with planned assessments. - Severe pathology unbalanced or interfering with planned assessments. - Participation in another study that may interfere with this study. - Neurological deficit including antecedent of epileptic pathology, photosensitive epilepsies, non-visual sensory disturbances, motor disorders, or sensorimotor coordination disorders, vestibular or cerebellar pathology. - Inability to give consent personally. - Adults protected by law. |
Country | Name | City | State |
---|---|---|---|
France | Institut de la vision | Paris |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Eye movements | Eye movements will be recorded by an eye trackervisual impairment whose peripheral visual field is masked They will be invited to observe scenes of human interaction presented on photographs, pictorial works or artificial scenes with or without prior instruction. In addition to the elementary variables recorded during the exploration by these subjects, such as the number, the amplitude or the orientation of the saccades, the sequence of fixations will be analyzed to define the exploratory strategy used. |
through study completion,, an average of 1 year | |
Primary | Fixation strategy | The fixation strategy characterized by the path of the gaze of the subjects on the screen to locate the targets. | through study completion,, an average of 1 year | |
Primary | Target location accuracy | Target location accuracy, defined by the distance between the point of re-fixation on the target and the actual position of the target | through study completion,, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05179460 -
A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy
|
||
Recruiting |
NCT05643157 -
Cellular Scale Measures of Short-Term Retinal Atrophy Progression
|
||
Recruiting |
NCT04419285 -
Mobility Protocol Adapted for Advanced Visually Impaired Subjects
|
N/A | |
Recruiting |
NCT03510234 -
Self-confidence Study in Patients With Argus II Artificial Retina
|